参考文献

[1]Fox KA,Anderson FA Jr,Dabbous OH,et al.Intervention in acute coronary syndromes:do patients undergo intervention on the basis of their risk characteristics.The Global Registry of Acute Coronary Events(GRACE).Heart,2007,93:177-182.

[2]Babaev A,Frederick PD,Pasta DJ,et al.Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.JAMA,2005,294:448-454.

[3]Robert J,Goldberg B,Frederick A,et al.Thirty year trends(1975-2005)in the magnitude,management,and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction:a population-based perspective.Circulation,2009,119:1211-1219.

[4]Debrunner M,Schuiki E,Minder E,et al.Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock.Clin Res Cardiol,2008,97:298-305.

[5]Chen ZM,Pan HC,Chen YP,et al.Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction:randomised placebo-controlled trial.Lancet,2005,366:1622-1632.

[6]Russ M,Prondzinsky R,Christoph A,et al.Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.Crit Care Med,2007,35:2732-2739.(https://www.daowen.com)

[7]Christoph A,Prondzinsky R,Russ M,et al.Early and sustained haemodynamic improvement with levosimendan compared to intra-aortic balloon counterpulsation(IABP)in cardiogenic shock complicating acute myocardial infarction.Acute Card Care,2008,10:49-57.

[8]Formica F,Avalli L,Martino A,et al.Extracorporeal membrance oxygenation with a polymethylpentene oxygenator(Quadrox D).The experience of a single Italian centre in adult patients with refractory cardiogenic shock.ASAIO J,2008,54:89-94.

[9]Kim H,Lim SH,Hong J,et al.Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock.Resuscitation,2012.6:21-25.

[10]Jin MC,Corstiaan A,Sanne Ehoeks.Percutaneous left ventricular assist devices vs intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock:a meta-analysis of controlled trials.European Heart Journal,2009,30:2102-2108.

[11]Marcolino MS,Simsek C,de Boer SP,et al.Short-and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock.Cardiology,2012,121:47-56.